Előadást letölteni
Az előadás letöltése folymat van. Kérjük, várjon
KiadtaAdrián Somogyi Megváltozta több, mint 9 éve
1
A spin-off SME from Pharmapolis Innovative Pharmaceutical Cluster Debrecen Biomarker development in the interface of industry and clinics Tilburg, 9/8/2011
2
Pharma Cluster Debrecen 1.Traditions 2.Pharmapolis concept 3.Triple helix 4.Strategic fields 5.Founders – members 6.Cluster life cycle 7.Projects
3
Project Companies CERORIN Ltd. Development of preprandial and bedtime oral insulin preparation Pharmatom Ltd. PET radioligand development for characterization of binding of drugs and drug candidates to HERG channels BioDiagnostica Ltd. Pulmonary Cancer Diagnosys Development
4
Who we are? What is UD-GenoMed? Core facility DCGC Service provider for industy Functional genomics Several projects to IP portfolio development
5
History Sept. 2007 Foundation of UDG 2008project planning, proposal writing, services starting 2009new projects, new services (Affy workstation) 2010capital raising by individuals, EU grants, industry financed R&D projects 2011Cell and protein engineering
6
Services
7
Services 2 RT PCR – Consultation – Q PCR Assay – Genotyping qPCR Assay (SNP detection) – Low Density Array (Microfluidics Card) Agilent Bioanalyzer (RNA Nano Chip, RNA Pico Chip, DNA Chip) Affymetrix m icroarray Sequencing and fragment analysis NGS
8
Referenses Collaborating partnersTrading partnersCustomers
9
Thank you for your kind attention!
11
Projektek, K+F szerződéses munkák 1.SCHIZO-08- Nagy László / Zahuczky Gábor 2.EPIGEN09+- Bálint László Bálint 3.TRANSCOM- Fésüs László 4.RA, IBS biomarker kutatás – Meskó Bertalan 5.Globális génexpressziós analízisek – Póliska Szilárd 6.Ig v régió szekvenálás – Zahuczky Gábor 7.Preklinikai vizsgálatok – Pap Attila
Hasonló előadás
© 2024 SlidePlayer.hu Inc.
All rights reserved.